-
ADMS Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Adamas Pharmaceuticals (ADMS)
Company Profile
Quarter (USD) | Sep 21 | Jun 21 | Mar 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 78.62 mm | 78.62 mm | 78.62 mm | 78.62 mm | 78.62 mm | 78.62 mm |
Cash burn (monthly) | 3.39 mm | (no burn) | 1.88 mm | 3.27 mm | 2.08 mm | 3.90 mm |
Cash used (since last report) | 139.32 mm | n/a | 77.18 mm | 134.52 mm | 85.52 mm | 160.26 mm |
Cash remaining | -60.70 mm | n/a | 1.44 mm | -55.89 mm | -6.89 mm | -81.64 mm |
Runway (months of cash) | -17.9 | n/a | 0.8 | -17.1 | -3.3 | -20.9 |
13F holders | Current |
---|---|
Total holders | 2 |
Opened positions | 1 |
Closed positions | 60 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 25.77 mm |
Total shares | 3.23 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Magnetar Financial | 3.13 mm | $25.28 mm |
Healthcare Value Capital | 100.00 k | $491.00 k |
Hirschman Orin | 0.00 | $0.00 |
Stonepine Capital Management | 0.00 | $0.00 |
Armistice Capital | 0.00 | $0.00 |